The shares of pharmaceuticals companies recorded a fall today following an order by the Department of Pharmaceuticals that would put price control of drugs and make them cheaper in the country. According to the latest information available, the ... Topnews.in, 2 hours ago
Drug pricing policy to have limited impact - Financial Express, 5 hours ago
New drug policy to hit profitability of firms - Money Today, 1 day ago
More from: First Post.com, DNA...and 10 other sources
See all (52) images for "drugs price control order"
Prices of 348 essential medicines will come down in the state, thanks to a new drug price control order by the Department of Pharmaceuticals. Sources say the prices of these drugs will be reduced by as much as 10-20 per cent, once the new pricing ...New Indian Express, 10 hours ago Centres new control order to slash drug prices in Kerala The Hindu, 22 hours ago Prices of several life-saving drugs to drop by up to 80% Stockwatch.in, 10 hours ago New price control regime to cut drugs cost by up to 80% Firstpost.com, 1 day ago
There is no classification as life saving drugs/medicines under Drugs (Prices Control) Order, 1995 (DPCO, 1995). Under the provisions of the DPCO, 1995, the prices of 74 scheduled bulk drugs and the formulations containing any of these scheduled ...Press Information Bureau, 2 weeks ago Sale of Medicines under NLEM at Exorbitant Price PIB, 3 weeks ago COLUMN: Struggle for life saving drugs Rediff.com, 1 month ago Prices of Drugs PIB, 1 month ago
The domestic pharmaceutical market is expected to witness value erosion of around Rs 1,600 crore due to the Drug Price Control Order (DPCO) 2013, to take effect by the first week of July, at the latest. The existing order it replaces dates back to ...Sify, 19 hours ago DPCO: pharma market to witness Rs 1,600-cr value erosion Business Standard, 1 day ago BSE Sensex choppy; pharma drags, realty gains Moneycontrol.com, 1 day ago
With about three-fourth of Indians spending their own money for medical treatment, this must be great news. But in reality, it's not; instead it's a wasted opportunity which perhaps has been dictated by the interests of the pharma lobby. Getty Image ...Firstpost.com, 1 day ago Why the new drug price control is unexciting for most of us Firstpost.com, 1 day ago
The Supreme Court decision denying Novartis a patent for the cancer drug imanitib has been hailed as a victory for the affordable medicines movement. But it won't make much difference if doctors continue to prescribe expensive branded drugs, ...InfoChange, 1 day ago Will Indian patent case end drugs companies monopoly? EHospice, 2 weeks ago Indian Patents Act: Incentivising Innovation without compromising affordable healthcare Bar & Bench, 1 week ago
The two companies that make vaccines against cervical cancer announced Thursday that they would cut their prices to the world's poorest countries below $5 per dose, eventually making it possible for millions of girls to be protected against a major ...Individual.com, 5 days ago Cervical Cancer Vaccine Prices Cut for the Poor New York Times, 1 week ago Cancer Vaccines Get a Price Cut In Poor Nations New York Times, 1 week ago
Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has denied a price rise for some imported products of Sanofi, Novartis, and Allergan. In a meeting earlier this month, the regulator rejected price revision applications for ...Smart Investor, 1 week ago NPPA denies price hike to Sanofi, Novartis, Allergan Smart Investor, 1 week ago Imported insulin to cost more Rediff.com, 2 months ago
The department of pharmaceuticals turned down a review petition by drugmaker Cipla against a price fixation order by the National Pharmaceutical Pricing Authority, slashing the price of Dytor Plus, a medicine for kidney and heart ailments. DoP said since the company had not informed whether the price fixed had been implemented, there was no question of a review. It has asked the regulator to recover if there is any amount overcharged by the firm on sales of the drug.“Based on the record ...Rediff.com, 4 weeks ago
The Indian pharmaceutical market size in terms of value will likely come down by Rs.1,600 crore C.H. Unnikrishnan Drug makers have 45 days from the date of the notification of the new rules to introduce the newly priced medicine packs. The drugs ...Livemint.com, 1 day ago
on your WebpageAdd Widget >Get your members hooked!